InsiderClue
Insiders · Profile

SIEGALL CLAY B

Director at Shattuck Labs · President and CEO at Immunome · Director at Ultragenyx Pharmaceutical. Filing since 7 Aug 2020. CIK 0001167496

STTK Shattuck Labs, Inc. Director · 1 trade IMNM Immunome Inc. President and CEO · 11 trades RARE Ultragenyx Pharmaceutical Inc. Director · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
STTK Shattuck Labs, Inc.
9 Jun 2026
Director
Bought
62,500
$250.00K
24.4%
IMNM Immunome Inc.
27 Mar 2026
President and CEO
Bought
25,450
$500.60K
3.8%
IMNM Immunome Inc.
30 Dec 2025
President and CEO
Bought
4,729
$100.02K
0.7%
IMNM Immunome Inc.
19 Dec 2025
President and CEO
Bought
7,278
$149.05K
0.9%
IMNM Immunome Inc.
18 Dec 2025
President and CEO
Bought
46,511
$999.99K
5.8%
IMNM Immunome Inc.
26 Mar 2025
President and CEO
Bought
137,100
$999.46K
20.5%
IMNM Immunome Inc.
31 Jan 2025
President and CEO
Bought
150,000
$1.16M
28.9%
IMNM Immunome Inc.
22 Nov 2024
President and CEO
Bought
33,943
$331.92K
7.0%
IMNM Immunome Inc.
21 Nov 2024
President and CEO
Bought
66,057
$630.26K
15.7%
IMNM Immunome Inc.
21 May 2024
President and CEO
Bought
20,434
$281.55K
5.1%
IMNM Immunome Inc.
20 May 2024
President and CEO
Bought
79,566
$1.11M
24.9%
IMNM Immunome Inc.
2 Oct 2023
President and CEO
Bought
169,204
$1,000.00K
112%
RARE Ultragenyx Pharmaceutical Inc.
10 Aug 2020
Director
Sold, plan not stated
11,346
$964.52K
81.6%
RARE Ultragenyx Pharmaceutical Inc.
7 Aug 2020
Director
Sold, plan not stated
23,404
$2.00M
65.6%
14 decisions on file.